Position history for BlackRock, Inc.'s holdings in RHYTHM PHARMACEUTICALS INC
BlackRock, Inc. holds 6.3M shares of RYTM (RHYTHM PHARMACEUTICALS INC), worth $674.1M as of 2025-Q4. The position was decreased (-0.1% shares). RYTM represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$674.1M
Current Shares
6.3M
Total Value Change
+$285M
Total Shares Change
-653,381
Other major holders of RYTM: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, RA CAPITAL MANAGEMENT, L.P.
Decreased |
| 6.3M |
-0.1% |
| $674.1M |
| 0.0% |
| $106.76 |
0 |
| 2025-Q3 | Increased | 6.3M | +0.6% | $636.5M | 0.0% | $100.64 | 32 |
| 2025-Q2 | Decreased | 6.3M | -8.6% | $396M | 0.0% | $62.73 | 0 |
| 2025-Q1 | Decreased | 6.9M | -1.4% | $363.1M | 0.0% | $54.80 | 0 |
| 2024-Q4 | New | 7M | - | $389.1M | 0.0% | $56.34 | 43 |